STAT News · Scour

STAT+: Moderna’s reset hinges on oncology

statnews.com·10w

STAT+: Servier to acquire Day One, maker of pediatric cancer drug, for $2.5B

statnews.com·10w

STAT+: Pharmalittle: We’re reading about an FDA-UniQure tussle, a Pfizer obesity drug approval in China, and more

statnews.com·10w

Americans trust Fauci more than RFK Jr.

statnews.com·10w

How the ‘holy grail’ weight loss pill became a reality, and what comes next

statnews.com·10w

Opinion: What’s so religious about opposing vaccines?

statnews.com·10w

How Stand Up For Science is trying to ‘pull every lever’ to win over the public

statnews.com·10w

In its campaign against gender-affirming care, Trump administration seeks to clear a big legal hurdle

statnews.com·10w

Opinion: U.S. needs a national prevention infrastructure for mental and behavioral disorders

statnews.com·10w

Across ERs, Tylenol orders for pregnant people dropped after health officials linked drug to autism

statnews.com·10w

STAT+: Omada reports first profitable quarter as it seizes broad GLP-1 opportunity

statnews.com·10w

STAT+: Science Corp. raises $230 million to bring retinal implant to Americans

statnews.com·10w

STAT+: Patient health data as a public utility: A former ARPA-H data chief explains

statnews.com·10w

Breaching the IBD efficacy ceiling, and sham surgeries

statnews.com·10w

STAT+: TrumpRx’s slow start

statnews.com·10w

STAT+: A drug company with a side of gold?

statnews.com·10w

Pediatric nicotine exposure shifts with trends

statnews.com·10w

STAT+: Pharmalittle: We’re reading about TrumpRx shortcomings, Lilly targeting employers, and more

statnews.com·10w

STAT+: The extremism of the FDA’s Marks and Prasad has come with costs

statnews.com·10w

STAT+: Eli Lilly launches program for employers to subsidize cost of obesity drug outside insurance

statnews.com·10w

Log in to enable infinite scrolling